| __timestamp | Agios Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 5903000 |
| Thursday, January 1, 2015 | 141827000 | 2762000 |
| Friday, January 1, 2016 | 220163000 | 1114000 |
| Sunday, January 1, 2017 | 292681000 | 25573000 |
| Monday, January 1, 2018 | 1397000 | 6000000 |
| Tuesday, January 1, 2019 | 1317000 | 38845000 |
| Wednesday, January 1, 2020 | 2805000 | 50523000 |
| Friday, January 1, 2021 | 18777000 | 75463000 |
| Saturday, January 1, 2022 | 1704000 | 105767000 |
| Sunday, January 1, 2023 | 9504000 | 167512000 |
| Monday, January 1, 2024 | 4165000 |
In pursuit of knowledge
In the ever-evolving landscape of biopharmaceuticals, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis delves into the cost of revenue trends for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Agios Pharmaceuticals experienced a significant fluctuation, with a peak in 2017, where costs soared to nearly 300% of their 2014 levels. However, by 2023, their costs had decreased by approximately 90% from the 2017 peak, indicating a strategic shift or operational efficiency.
Conversely, Xenon Pharmaceuticals showcased a steady upward trajectory, with costs increasing by over 2800% from 2014 to 2023. This growth reflects their aggressive expansion and investment in research and development. The contrasting trends between these two companies highlight the diverse strategies within the biopharmaceutical sector, offering valuable insights for investors and industry analysts.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Neurocrine Biosciences, Inc. vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Agios Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.